Year: 2022

news_6

SHIONOGI SIGNS AGREEMENT WITH NHS ENGLAND TO BEGIN AN INNOVATIVE SUBSCRIPTION PAYMENT MODEL FOR REIMBURSEMENT OF ITS ANTIBIOTIC, FETCROJA®? (CEFIDEROCOL)

Shionogi and NHS England have signed an agreement to begin an innovative subscription payment model for reimbursement of cefiderocol in...